Foundation Medical Partners Welcomes Ted Laufik as Partner and CFO
Laufik Brings Investment, Technology, and Financial Expertise to Team
ROWAYTON, CT, March 20, 2013-- Foundation Medical Partners, a national healthcare venture capital investment firm, today announced that Ted Laufik has joined the team as a Partner and CFO. Mr. Laufik joins Foundation's team to manage investments in the connected health and healthcare IT sectors.
Mr. Laufik has had a long and successful career in venture capital. Most recently, until 2011, he served as Partner and CFO at Morgenthaler, a national venture capital and private equity firm. He served as CFO since 1985 and Partner since 1995. During his tenure, Morgenthaler raised $3 billion in capital, made investments in over 300 companies, and managed a diverse portfolio from early stage IT and healthcare technology companies to middle market buyout businesses.
"Ted brings significant depth and financial capability to Foundation," said Lee Wrubel, Managing Partner of Foundation Medical Partners. "Ted has worked in the industry with top notch LPs, general partners, and entrepreneurs -- and he brings that experience to our firm."
Mr. Laufik joins the investment team at Foundation Medical Partners that includes partners Andrew Firlik, Lee Wrubel, and Kevin Sharer. The firm actively manages over $200 million in venture capital targeted toward start-up and early-stage companies. Foundation has remained exclusively focused on the healthcare technology market since the firm was founded in 2001, with a current market capitalization of its healthcare investments totaling approximately $2.0 billion.
About Foundation Medical Partners
Foundation Medical Partners is a national venture capital investment firm formed in 2001 with the vision of bringing together cutting edge healthcare expertise with deep company building experience. Foundation specializes in early stage venture capital for healthcare technology companies. Foundation Medical Partners was an early, active venture investor in many companies that subsequently went public or were acquired in strategic transactions, such as AtriCure (NASDAQ: ATRC), CardioNet (NASDAQ: BEAT), Combinatorx (NASDAQ: ZLCS), Immunicon (NASDAQ: IMMC, later acquired by Johnson & Johnson), Northstar Neuroscience (NASDAQ: NSTR, later acquired by St. Jude Medical), and Visiogen (acquired by Abbott), as well as a portfolio of other market-leading privately held firms.
For press correspondence, please contact
ANDREW D. FIRLIK, MD
Foundation Medical Partners
105 Rowayton Avenue
Rowayton, CT 06853
Downloadable Venture Capital Database